Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
6.63
-0.27 (-3.91%)
Nov 20, 2025, 1:09 PM EST - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $52.75 million as of November 20, 2025. Its market cap has decreased by -73.91% in one year.
Market Cap
52.75M
Enterprise Value
112.68M
1-Year Change
-73.91%
Ranking
Category
Stock Price
$6.63
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $52.75M, a decrease of -84.32%. That is a compound annual growth rate of -30.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 54.89M | -75.34% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |